US2023398117A1PendingUtilityA1
3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide Derivatives
Est. expiryMar 26, 2038(~11.7 yrs left)· nominal 20-yr term from priority
Inventors:Luca AristaChristina HebachGregory John HollingworthPhilipp HolzerPatricia Imbach-WeeseRainer MachauerNiko SchmiedebergAnna VulpettiThomas Zoller
A61K 31/519A61P 35/00C07D 487/04C07D 519/00
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to compounds of the formula (I) or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
15 . A compound of Formula (XXIa):
or a salt thereof,
wherein:
R 6 is selected from H and F; and
R 7 is selected from H, F, Cl, —CH 3 , —OCH 3 , and —OCH 2 CH 3 .
16 . The compound of claim 1 , or a salt thereof, wherein R 6 is F.
17 . The compound of claim 1 , or a salt thereof, wherein R 7 is selected from F, Cl, —CH 3 , —OCH 3 , and —OCH 2 CH 3 .
18 . The compound of claim 1 , or a salt thereof, which is:
or a salt thereof.Join the waitlist — get patent alerts
Track US2023398117A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.